Fuhao Chu, Yongyue Wang, Chenyang Rao, Xingkang Deng, Haili Wang, Yundong Wu, Xiaowei Xiang, Qing Hu, Jiaolong Huang, Shaopan Bao, Tao Fang
Although previous zebrafish studies have reported developmental, immune, intestinal, and reproductive effects of 2,4-di-tert-butylphenol (2,4-DTBP), evidence linking adult neurobehavioral outcomes with brain neurotransmitter-related changes and histopathological responses remains limited. Herein, we employed a zebrafish model subjected to a 21-day exposure across an environmentally informed and sublethal concentration range (0.01-1 μM), integrating a multi-tiered assessment that combined behavioral assays, biochemistry, molecular biology, histopathology, and computational toxicology. Our results showed reduced upper-zone exploration in the Novel Tank Test (p < 0.05) and endpoint-specific variation in social approach-related measures in the social preference test. These behavioral changes were accompanied by vascular-adjacent and parenchymal histopathological alterations in the brain. At the molecular level, 2,4-DTBP exposure altered cholinergic and serotonergic endpoints, including ACh accumulation, 5-HT depletion, and selective transcriptional changes involving slc5a7a and tph2. Notably, bdnf expression was markedly upregulated (p < 0.001), consistent with a stress-related or injury-associated transcriptional response. Molecular docking predicted a pose of 2,4-DTBP within the acetylcholinesterase (AChE) aromatic gorge, with a favorable Vina score (≈ -7.57 kcal/mol) and predicted π-π/hydrophobic interactions with aromatic residues. Collectively, these findings support the use of a putative AOP-informed framework to organize neurotransmitter-related alterations, vascular-associated and parenchymal histopathological changes, and anxiety-like behavioral responses in adult zebrafish exposed to 2,4-DTBP.